Expression of immune checkpoint regulators, programmed death-ligand 1 (pd-l1/pd-1), cytotoxic t lymphocyte antigen 4 (ctla-4), and indolaimine-2, 3-deoxygenase (ido) in uterine mesenchymal tumors

HIGHLIGHTS

• who: Alireza Samiei from the Department of Pathology and Laboratory Medicine, David Geffen School Angeles, CA, u20111732, USA have published the research work: Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors, in the Journal: (JOURNAL)
• what: The aim of this study was to examine the expression of the immune check-point proteins in uterine mesenchymal neoplasms, to help direct the future clinical development of novel immune check-point inhibitor therapies.
• future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.